Regeneron says its Covid-19 treatment reduces viral levels, improves symptoms

REGN-COV2 is part of a class of biotech therapies known as monoclonal antibodies. Several companies are using the technology to manufacture copies of human antibodies to the new coronavirus.

from Hindustan Times - world https://bit.ly/33dKatk
https://ift.tt/2zbki14